Q4 2015

Filed Feb 18, 2016 · 10-K · 49 days after period end · 0000877860-16-000104

Q4 2015 · 10-K

Revenue

$58.64M

+28.2% vs Q4 2014

Net Income

$54.40M

+97.6% vs Q4 2014

EPS Diluted

$1.44

+80.0% vs Q4 2014

Operating Cash Flowderived$43,629,000+32.5%

Same quarter

Metric	Q4 2015	Q4 2014	Q4 2013	Q4 2012
Revenue	$58.64M	$45.74M	$32.79M	$25.87M
Net Income	$54.40M	$27.53M	$27.78M	$41.11M
EPS Diluted	$1.44	$0.80	$0.93	$1.47

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR